1 Min Read
March 23 (Reuters) - Idogen AB:
* European Patent Office will formally grant a patent application, covering company’s tolerogenic vaccine technology Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.